<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
Advanced Health Corporation
-----------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------
(Title of Class of Securities)
00756H 10 8
-----------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five
percent of the class of securities described in Item 1; and (2) has
no amendment subsequent thereto reporting beneficial ownership of five
percent or less of such class.) (See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
(Continued on following page(s))
Page 1 of 6 Pages
<PAGE> 2
CUSIP NO. 00756H 10 8 13G PAGE 2 OF 6 PAGES
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Jonathan Edelson, M.D.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
5 SOLE VOTING POWER
819,875
(including 401,288 currently exercisable options)
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 819,875
(including 401,288 currently exercisable options)
8 SHARED DISPOSITIVE POWER
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
819,875
(including 401,288 currently exercisable options)
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES *
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.1%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 3
Item 1. (a). Name of Issuer:
Advanced Health Corporation
(b). Address of Issuer's Principal Executive Offices:
555 White Plains Road
Tarrytown, NY 10591
Item 2. (a). Name of Person Filing:
Jonathan Edelson, M.D.
(b). Address of Principal Business Office:
555 White Plains Road
Tarrytown, N.Y. 10591
Page 3 of 6 Pages
<PAGE> 4
Item 2. (c). Citizenship:
USA
(d). Title of Class of Securities:
Common Stock
(e). CUSIP Number:
00756H 10 8
Item 3. This statement is filed pursuant to Rule 13d-1(b), or
13d-2(b) by
Item 4. Ownership.
(a). Amount Beneficially Owned
819,875
(including 401,288 currently exercisable options)
(b). Percent of Class:
8.1%
(c). Number of Shares as to which such person has:
(i) sole power to vote or to direct the vote: 819,875
(ii) shared power to vote or to direct the vote: n/a
(iii) sole power to dispose or to direct the
disposition of: 819,875
(iv) shared power to dispose or to direct the
disposition of: n/a
Page 4 of 6 Pages
<PAGE> 5
Item 5. Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as
of the date herof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following [ ].
Item 6. Ownership of More Than Five Percent on Behalf of Another
Person:
Not applicable.
Item 7. Identification and Classification of Subsidiaries which
Acquired the Security Being Reported on by the Parent
Holding Company:
Not applicable
Item 8. Identification and Classification of Members of the Group:
Not applicable.
Page 5 of 6 Pages
<PAGE> 6
Item 9. Notice of Dissolution of Group:
Not applicable.
Item 10. Certification:
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired
in the ordinary course of business and were not acquired for
the purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in
any transaction having such purpose or effect.
Signature: After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set
forth in this statement is true, complete and correct.
By: /s/ Jonathan Edelson
------------------------
Title: Chairman and CEO
Dated: February 12, 1999
Page 6 of 6 Pages
